Latest Industry Articles

New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha and Gamma variants following third dose booster with Vaxzevria Additional analysis showed increased antibody response to Omicron after a third dose   Positive results from a prelimina

Human rights, employment, the environment and the fight against corruption are the pillars behind the 2030 Agenda and Esaote’s commitment to positioning its business within the multidisciplinary One Health approach. Genoa, January 13th, 2022 – The Board of Directors of Esaote , a leading Ita

Pfizer Inc Chief Executive Albert Bourla said a redesigned COVID-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company could have one ready to launch by March. Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted

Affidea , the largest European provider of diagnostic imaging, outpatient and cancer care services continues to invest in Italy and has today announced the 100% acquisition of Promea Center, a renowned outpatient provider in Piedmont region, Italy, specialized in o

For the first time, Healthcare Transformation Talks will take place on the show floor, alongside the biggest disrupters in the healthcare industry with world-renowned experts, innovators, and industry leaders discussing the latest innovations in the sector. Dubai, United Arab Emirates

PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets) is authorized for emergency use in both high-risk adults and high-risk pediatric patients 12 years of age and older weighing at least 40 kg EUA based on clinical data from EPIC-HR study, showing PAXLOVID reduced risk of hosp

Healthcare Systems at a Crossroads: What’s Next from Here?  EHMA 2022 is the 27th Annual Conference of the European Health Management Association taking place in conjunction with the association’s 40th anniversary. It will bring together key healthcare stakeholders in Brussels providing

Second strategy phase “Upgrading” completed one year ahead of schedule New Ambition addresses the greatest opportunities in healthcare: fighting the most threatening diseases, enabling efficient operations, expanding access to care Comparable revenue growth of 6 to 8 percent p.a. and adjusted EP

Affidea , the largest European provider of diagnostic imaging, outpatient and cancer care services   continues to invest in the Italian market and has today announced the 100% acquisition of Medical Sport Center and Medical Center, two flagship medical centers in   Lod

Health-care giant Johnson & Johnson is splitting off its consumer division, following in the footsteps of other big drugmakers that have moved to focus on the more-profitable pharmaceutical market.   The consumer division will be separated in 18 to 24 months, the company said in a state